Pharma leaders declare war on antibiotic resistance at Davos

More than 80 pharma companies, including animal health leaders Merck ($MRK) and Sanofi ($SNY), signed a declaration on combating antimicrobial resistance at the World Economic Forum in Davos on Jan. 21. The declaration, which was also signed by 9 industry associations, supports several initiatives aimed at improving how antibiotics are prescribed in both animal and human health, such as promoting more judicious antibiotics use in livestock. It also appeals to governments, insurers and healthcare providers to remove any financial incentives awarded to professionals--including veterinarians--for prescribing antibiotics in high volumes. Release (PDF)

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…